Functional Neuromodulation gets FDA breakthrough device status for Vercise DBS system
The Vercise DBS systems have been designed to treat patients 65 years and older with mild probable Alzheimer's…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Jan 21
The Vercise DBS systems have been designed to treat patients 65 years and older with mild probable Alzheimer's…
29 Dec 20
The Simoa semi-quantitative SARS-CoV-2 IgG antibody test is designed to run on the Simoa HD-X Analyzer to detect…
24 Dec 20
Solana SARS molecular test will facilitate the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and nasal…
24 Dec 20
The EndoRotor system will help resect and remove necrotic tissue in patients with walled-off pancreatic necrosis
23 Dec 20
Drivewire, claimed to be the first neurovascular guidewire with a controllable distal end, allows to conduct difficult neuro…
22 Dec 20
QuickVue SARS antigen test will help identify suspected Covid-19 individuals within the first five days of the onset…
22 Dec 20
Ingenion will use the proceeds over the next six months to gain a CE Mark for its CymActive…
21 Dec 20
The SCONE uses negative pressure technology to create "active" barrier protection, helping hospitals reduce the risk of infectious…
18 Dec 20
The less invasive bio-engineered BEAR implant is developed to restore natural anatomy and function of the knee
18 Dec 20
Abbott's HeartMate 3 heart pump approved for use for pediatric patients battling advanced heart failure and the life-saving…